[EN] COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF KRAS<br/>[FR] COMPOSÉS ET MÉTHODES DE DÉGRADATION CIBLÉE DE KRAS
申请人:ARVINAS OPERATIONS INC
公开号:WO2023141570A2
公开(公告)日:2023-07-27
Bifunctional compounds, which find utility as modulators of Kirsten ras sarcoma protein (KRAS), are described herein. In particular, the hetero-bifunctional compounds of the present disclosure contain on one end a moiety that binds to the Von Hippel-Lindau E3 ubiquitin ligase and on the other end a moiety which binds KRAS, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The hetero-bifunctional compounds of the present disclosure exhibit a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aberrant regulation of the target protein are treated or prevented with compounds and compositions of the present disclosure.
本文描述了可用作 Kirsten ras 肉瘤蛋白(KRAS)调节剂的双功能化合物。特别是,本公开的杂双官能化合物一端含有与 Von Hippel-Lindau E3 泛素连接酶结合的分子,另一端含有与 KRAS 结合的分子,从而将靶蛋白置于泛素连接酶附近,以实现对靶蛋白的降解(和抑制)。本公开的杂双官能团化合物具有与降解/抑制靶蛋白相关的多种药理活性。本发明公开的化合物和组合物可以治疗或预防由于靶蛋白调节失常而导致的疾病或失调。